Galecto Ownership
| GLTO Stock | USD 4.05 0.08 2.02% |
Galecto |
Galecto Stock Ownership Analysis
The company has price-to-book (P/B) ratio of 0.26. Some equities with similar Price to Book (P/B) outperform the market in the long run. Galecto recorded a loss per share of 19.11. The entity had not issued any dividends in recent years. The firm had 1:25 split on the 30th of August 2024. Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. Galecto, Inc. was founded in 2011 and is based in Boston, Massachusetts. Galecto operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people. To learn more about Galecto call the company at 45 70 70 52 10 or check out https://galecto.com.Besides selling stocks to institutional investors, Galecto also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Galecto's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Galecto's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Galecto Quarterly Liabilities And Stockholders Equity |
|
Galecto Insider Trades History
Roughly 3.0% of Galecto are currently held by insiders. Unlike Galecto's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Galecto's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Galecto's insider trades
Galecto Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Galecto is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Galecto backward and forwards among themselves. Galecto's institutional investor refers to the entity that pools money to purchase Galecto's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | State Street Corp | 2024-09-30 | 0.0 | Susquehanna International Group, Llp | 2024-09-30 | 0.0 | Summit Trail Advisors, Llc | 2024-09-30 | 0.0 | Tower Research Capital Llc | 2024-12-31 | 0.0 | Commonwealth Equity Services Inc | 2024-09-30 | 0.0 | Northern Trust Corp | 2024-09-30 | 0.0 | Spire Wealth Management | 2024-09-30 | 0.0 | Citadel Advisors Llc | 2024-09-30 | 0.0 | Vanguard Group Inc | 2024-09-30 | 0.0 | Novo A/s | 2024-12-31 | 99.9 K | Renaissance Technologies Corp | 2024-12-31 | 15 K |
Galecto Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Galecto insiders, such as employees or executives, is commonly permitted as long as it does not rely on Galecto's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Galecto insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Galecto Outstanding Bonds
Galecto issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Galecto uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Galecto bonds can be classified according to their maturity, which is the date when Galecto has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| ADGLXY 2625 31 MAR 36 Corp BondUS36321PAB67 | View | |
| ADGLXY 175 30 SEP 27 Corp BondUS36321PAA84 | View | |
| ADGLXY 216 31 MAR 34 Corp BondUS36321PAD24 | View | |
| ADGLXY 294 30 SEP 40 Corp BondUS36321PAE07 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Galecto Corporate Filings
| 16th of January 2025 Other Reports | ViewVerify | |
F4 | 7th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 7th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
10Q | 1st of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Pair Trading with Galecto
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Galecto position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galecto will appreciate offsetting losses from the drop in the long position's value.Moving together with Galecto Stock
| 0.63 | VRCA | Verrica Pharmaceuticals | PairCorr |
| 0.7 | ENVB | Enveric Biosciences Earnings Call This Week | PairCorr |
Moving against Galecto Stock
| 0.67 | IVA | Inventiva Sa | PairCorr |
| 0.59 | LLY | Eli Lilly | PairCorr |
| 0.55 | PBH | Prestige Brand Holdings | PairCorr |
| 0.4 | MGTX | MeiraGTx Holdings PLC Downward Rally | PairCorr |
| 0.34 | KRYS | Krystal Biotech | PairCorr |
The ability to find closely correlated positions to Galecto could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Galecto when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Galecto - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Galecto to buy it.
The correlation of Galecto is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Galecto moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Galecto moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Galecto can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Galecto. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Galecto Stock, please use our How to Invest in Galecto guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Galecto. If investors know Galecto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Galecto listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Galecto is measured differently than its book value, which is the value of Galecto that is recorded on the company's balance sheet. Investors also form their own opinion of Galecto's value that differs from its market value or its book value, called intrinsic value, which is Galecto's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Galecto's market value can be influenced by many factors that don't directly affect Galecto's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Galecto's value and its price as these two are different measures arrived at by different means. Investors typically determine if Galecto is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Galecto's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.